Home Other Building Blocks 10,11-Dihydro-5H-dibenzo[b,f]azepine-5-carboxamide

10,11-Dihydro-5H-dibenzo[b,f]azepine-5-carboxamide

CAS No.:
3564-73-6
Catalog Number:
AG003DTS
Molecular Formula:
C15H14N2O
Molecular Weight:
238.2845
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
Product Description
Catalog Number:
AG003DTS
Chemical Name:
10,11-Dihydro-5H-dibenzo[b,f]azepine-5-carboxamide
CAS Number:
3564-73-6
Molecular Formula:
C15H14N2O
Molecular Weight:
238.2845
MDL Number:
MFCD00005072
IUPAC Name:
5,6-dihydrobenzo[b][1]benzazepine-11-carboxamide
InChI:
InChI=1S/C15H14N2O/c16-15(18)17-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)17/h1-8H,9-10H2,(H2,16,18)
InChI Key:
PHNLCHMJDSSPDQ-UHFFFAOYSA-N
SMILES:
NC(=O)N1c2ccccc2CCc2c1cccc2
EC Number:
222-649-0
UNII:
EC017VA9FR
Properties
Complexity:
294  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
238.111g/mol
Formal Charge:
0
Heavy Atom Count:
18  
Hydrogen Bond Acceptor Count:
1  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
238.29g/mol
Monoisotopic Mass:
238.111g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
46.3A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2.3  
Literature
Title Journal
Update on treatment of partial onset epilepsy: role of eslicarbazepine. Neuropsychiatric disease and treatment 20100101
Molecular properties of psychopharmacological drugs determining non-competitive inhibition of 5-HT3A receptors. European journal of medicinal chemistry 20090601
An orthorhombic polymorph of 10,11-dihydrocarbamazepine. Acta crystallographica. Section C, Crystal structure communications 20060501
Effects of carbamazepine and novel 10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide derivatives on synaptic transmission in rat hippocampal slices. Pharmacology & toxicology 20020401
Properties